Morgan Herman is Executive Vice President, Development for Cure Alzheimer’s Fund. She has more than 20 years of experience, having served in leadership roles at New England Baptist Hospital, Boston Children’s Hospital, Beth Israel Deaconess Medical Center, and Dana-Farber Cancer Institute. As EVP, she leads a comprehensive Development program to significantly increase philanthropy for the organization. To date, CureAlz has supported over $100 million of grants with the highest probability of preventing, slowing, or reversing Alzheimer’s disease. Morgan and her team are committed to building upon that legacy with the ultimate goal of eradicating this disease.
Morgan earned her BA in English from Middlebury College and an MBA from Simmons College.